| For: | Chen JW, Liu CY, Li S, Wu SW, Cai C, Lu MQ. Sepsis-associated liver injury: Mechanisms and potential therapeutic targets. World J Gastroenterol 2024; 30(42): 4518-4522 [PMID: 39563749 DOI: 10.3748/wjg.v30.i42.4518] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i42/4518.htm |
| Number | Citing Articles |
| 1 |
Jianjun Wang, Yonghai Peng, Zhaohui Hu, Xi Chen, Sirui Chen, Pei Yang, Xintao Zeng, Decai Wang. Prognostic value of albumin-corrected anion gap in critically ill patients with sepsis-associated liver injury: a retrospective study. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-11321-7
|
| 2 |
Binglin Song, Ping Liu, Chun Liu, Kangrui Fu, Xiangde Zheng, Ying Liu. Development and validation of a predictive model for continuous renal replacement therapy in sepsis patients using the MIMIC-IV database. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-07647-6
|
| 3 |
Yuhan Liu, Yu Lei, Luorui Shang, Zhaomin Yu, Li Wang, Jiabin Zhou, Guangtao Pan. Protective effects of Dachengqi Decoction in sepsis-associated liver injury based on network pharmacology analysis and experimental validation. Journal of Ethnopharmacology 2025; 353: 120450 doi: 10.1016/j.jep.2025.120450
|
| 4 |
Zhen Yang, Xingyu Kao, Tianwei Zhu, Junna Lei, Na Huang, Jingli Chen, Mingfeng He, Qi Tang, Zhangrong Liang. Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1671732
|
| 5 |
Xinqi Xu, Tingyu Yang, Jiapan An, Bin Li, Zhimin Dou. Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1575554
|
| 6 |
Eleni V. Geladari, Anastasia-Amalia C. Kalergi, Apostolos A. Evangelopoulos, Vasileios A. Sevastianos. Sepsis and the Liver. Diseases 2025; 13(12): 388 doi: 10.3390/diseases13120388
|
| 7 |
Hilal Üstündağ, Songul Doganay. Septic Shock - From Pathophysiology to Patient Care. 2025; doi: 10.5772/intechopen.1009751
|
| 8 |
Yan Pan, Youting Xu, Ting Shui, Jiao Hong, Xuan Lu, Huilin Chen. Mesenchymal stem cell–derived small extracellular vesicles (sEVs) as a therapy for sepsis-related liver injury: evidence from a systematic review and meta-analysis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1707784
|
